1.21
price up icon0.00%   0.00
after-market Dopo l'orario di chiusura: 1.22 0.01 +0.83%
loading
Precedente Chiudi:
$1.21
Aprire:
$1.2
Volume 24 ore:
123.68K
Relative Volume:
0.10
Capitalizzazione di mercato:
$21.15M
Reddito:
-
Utile/perdita netta:
$-11.24M
Rapporto P/E:
-1.589
EPS:
-0.7615
Flusso di cassa netto:
$-4.79M
1 W Prestazione:
-6.20%
1M Prestazione:
-10.37%
6M Prestazione:
+6.14%
1 anno Prestazione:
+83.61%
Intervallo 1D:
Value
$1.18
$1.22
Intervallo di 1 settimana:
Value
$1.18
$1.29
Portata 52W:
Value
$0.51
$5.01

Mira Pharmaceuticals Inc Stock (MIRA) Company Profile

Name
Nome
Mira Pharmaceuticals Inc
Name
Telefono
813-369-5150
Name
Indirizzo
1200 BRICKELL AVENUE, MIAMI
Name
Dipendente
5
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
MIRA's Discussions on Twitter

Confronta MIRA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - General icon
MIRA
Mira Pharmaceuticals Inc
1.21 21.15M 0 -11.24M -4.79M -0.7615
Drug Manufacturers - General icon
LLY
Lilly Eli Co
775.90 724.64B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
155.92 376.43B 89.33B 21.81B 18.57B 8.99
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
69.82 352.49B 43.59B 15.04B 10.74B 3.3766
Drug Manufacturers - General icon
ABBV
Abbvie Inc
189.99 334.73B 57.37B 4.20B 15.39B 2.35
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
123.10 234.21B 53.22B 12.86B 14.85B 6.39

Mira Pharmaceuticals Inc Borsa (MIRA) Ultime notizie

pulisher
Jun 18, 2025

MIRA Pharmaceuticals' Lead Drug Candidate Ketamir-2 First Manuscript Accepted for Publication in the Peer-Reviewed Journal Frontiers in Pharmacology - Knoxville News Sentinel

Jun 18, 2025
pulisher
Jun 18, 2025

MIRA Pharmaceuticals’ ketamine analog accepted for publication By Investing.com - Investing.com Nigeria

Jun 18, 2025
pulisher
Jun 18, 2025

Breakthrough Ketamine Alternative Passes Key Scientific Review: Phase 2 Trial Coming - Stock Titan

Jun 18, 2025
pulisher
Jun 17, 2025

EON Resources Inc. Announcement - The Oklahoman

Jun 17, 2025
pulisher
Jun 17, 2025

MIRA Pharmaceuticals’ Ketamir-2 Published in Pharmacology Journal - TipRanks

Jun 17, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Buys Shares of 24,317 MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) - Defense World

Jun 14, 2025
pulisher
Jun 10, 2025

Citadel Advisors LLC Makes New $112,000 Investment in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) - Defense World

Jun 10, 2025
pulisher
Jun 06, 2025

60 Degrees Pharmaceuticals and Liberty Star Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - USA Today

Jun 06, 2025
pulisher
Jun 05, 2025

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Shares Acquired by Northern Trust Corp - Defense World

Jun 05, 2025
pulisher
May 30, 2025

MIRA Pharmaceuticals to Participate in BIO 2025 in Boston and Highlights Ongoing Progress Across Clinical Program - El Paso Times

May 30, 2025
pulisher
May 28, 2025

MIRA Pharmaceuticals (MIRA) Sets Sights on Major Advancements | - GuruFocus

May 28, 2025
pulisher
May 28, 2025

MIRA Pharmaceuticals (MIRA) Sets Sights on Major Advancements | MIRA Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

MIRA Pharmaceuticals Joins BIO Convention for Strategic Opportunities - TipRanks

May 28, 2025
pulisher
May 28, 2025

MIRA's Novel Pain Drug Shows Promise: Phase 1 Success Leads to Phase 2 Plans as Acquisition Nears - Stock Titan

May 28, 2025
pulisher
May 28, 2025

MIRA Pharmaceuticals announces clinical progress and acquisition update - Investing.com

May 28, 2025
pulisher
May 28, 2025

MIRA Pharmaceuticals announces clinical progress and acquisition update By Investing.com - Investing.com Nigeria

May 28, 2025
pulisher
May 25, 2025

MIRA Pharmaceuticals board approves SKNY Pharmaceuticals acquisition; combined value tops $60M - MSN

May 25, 2025
pulisher
May 21, 2025

MIRA Pharmaceuticals appoints new CFO - Investing.com Australia

May 21, 2025
pulisher
May 21, 2025

MIRA Pharmaceuticals Appoints New Chief Financial Officer - TipRanks

May 21, 2025
pulisher
May 21, 2025

MIRA Pharmaceuticals appoints new CFO By Investing.com - Investing.com UK

May 21, 2025
pulisher
May 11, 2025

MIRA Pharma Stock Soars To 2-Month High On $60M SKNY Deal: Retail Sentiment Strong - MSN

May 11, 2025
pulisher
May 11, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

May 11, 2025
pulisher
May 10, 2025

MIRA Pharmaceuticals (MIRA) Projected to Post Earnings on Monday - Defense World

May 10, 2025
pulisher
May 09, 2025

Why Mira Pharmaceuticals Inc (NASDAQ: MIRA) Is A Great Stock Pick For Momentum Investors - Stocksregister

May 09, 2025
pulisher
May 09, 2025

MIRA Pharma Stock Soars To 2-Month High On $60M SKNY Deal: Retail Sentiment Strong By Stocktwits - Investing.com India

May 09, 2025
pulisher
May 08, 2025

MIRA Pharmaceuticals Acquires SKNY Pharmaceuticals for $60M - TipRanks

May 08, 2025
pulisher
May 08, 2025

MIRA Pharmaceuticals to acquire SKNY in strategic move - Investing.com

May 08, 2025
pulisher
May 08, 2025

MIRA Pharmaceuticals Announces Board Approval of SKNY Acquisition Reflecting $60+ Million in Combined Enterprise Value Based on Independent Review - Corsicana Daily Sun

May 08, 2025
pulisher
May 08, 2025

EXCLUSIVE: Mira Pharmaceuticals Board Approves SKNY Pharma Acquisition, Establishing Combined Enterprise Value Over $60 Million - Benzinga

May 08, 2025
pulisher
May 08, 2025

Renaissance Technologies LLC Takes Position in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) - Defense World

May 08, 2025
pulisher
May 06, 2025

MIRA Pharmaceuticals Reports No Brain Toxicity in FDA-Required Study of Ketamir-2, Confirming Absence of Ketamine-Linked Neurotoxicity - The Joplin Globe

May 06, 2025
pulisher
May 06, 2025

MIRA Achieves Positive Safety Results in Neurotoxicity Study | M - GuruFocus

May 06, 2025
pulisher
May 06, 2025

EXCLUSIVE: MIRA Pharmaceuticals Lead Program Ketamir-2 Shows No Brain Toxicity In FDA-Mandated Study - AOL.com

May 06, 2025
pulisher
May 06, 2025

MIRA Pharmaceuticals reports safe profile for Ketamir-2 - Investing.com

May 06, 2025
pulisher
May 06, 2025

MIRA Pharmaceuticals reports safe profile for Ketamir-2 By Investing.com - Investing.com UK

May 06, 2025
pulisher
May 06, 2025

MIRA Pharmaceuticals Completes Key Neurotoxicity Study for Ketamir-2 - TipRanks

May 06, 2025
pulisher
May 06, 2025

Breakthrough: New Drug Outperforms Ketamine in FDA Brain Safety StudyZero Toxicity Detected - Stock Titan

May 06, 2025
pulisher
May 03, 2025

Pharmaceutical Stock Jumps After Key Trial Findings - MSN

May 03, 2025
pulisher
May 03, 2025

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Short Interest Down 14.1% in April - Defense World

May 03, 2025
pulisher
Apr 24, 2025

Mira Pharmaceuticals Inc [MIRA] moved up 7.08: Why It’s Important - dbtnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Financial Metrics Unveiled: Mira Pharmaceuticals Inc (MIRA)’s Key Ratios in the Spotlight - DWinneX

Apr 24, 2025
pulisher
Apr 23, 2025

MIRA Pharmaceuticals reports positive in vitro drug release data for topical Ketamir-2 - MSN

Apr 23, 2025
pulisher
Apr 23, 2025

Mira Pharmaceuticals announces key drug development milestone By Investing.com - Investing.com Canada

Apr 23, 2025
pulisher
Apr 23, 2025

Mira Pharmaceuticals announces key drug development milestone - Investing.com Australia

Apr 23, 2025
pulisher
Apr 23, 2025

MIRA Pharmaceuticals (MIRA) Advances Ketamir-2 Formulations in P - GuruFocus

Apr 23, 2025

Mira Pharmaceuticals Inc Azioni (MIRA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Mira Pharmaceuticals Inc Azioni (MIRA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Aminov Erez
Chief Executive Officer
Nov 20 '24
Sale
1.27
44,590
56,629
1,061,200
drug_manufacturers_general SNY
$49.05
price up icon 1.53%
$111.73
price up icon 0.78%
drug_manufacturers_general PFE
$25.04
price up icon 3.30%
$290.52
price up icon 4.05%
drug_manufacturers_general MRK
$81.81
price up icon 3.35%
drug_manufacturers_general NVS
$123.10
price up icon 1.73%
Capitalizzazione:     |  Volume (24 ore):